Claudio Zamagni
Policlinico S.Orsola-Malpighi(IT)Azienda USL di Bologna(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, PARP inhibition in cancer therapy, Cancer Treatment and Pharmacology
Most-Cited Works
- → Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial(2017)1,678 cited
- → Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study(2021)376 cited
- → Spatial predictors of immunotherapy response in triple-negative breast cancer(2023)286 cited
- → Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study(2018)169 cited
- → Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study(2018)152 cited
- →